IGMPI India

October 7, 2015

PAN Drugs receives warning letter from USFDA

MHRA issues recall notice of Lacri-Lube eye ointment

Another Import Ban for Polydrug Laboratories

Health Canada lifts its ban from two Apotex facilities in India

33 drugs were found to be of not of standard quality during Surprise inspection

Vivimed Labs successfully completes USFDA inspection of its manufacturing facility

October 7, 2015

PAN Drugs receives warning letter from USFDA

USFDA has recently issued a warning letter to PAN drugs Vadodara based plant due to significant deviations from good manufacturing practices.

MHRA issues recall notice of Lacri-Lube eye ointment

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall notice to Allergen Limited. The recall notice relates to 5g and 3.5g pack sizes of

Another Import Ban for Polydrug Laboratories

USFDA (Food and Drug Administration) issues import ban for products manufactured by Polydrug Laboratories. It was issued on Sept. 11, 2015 for

Health Canada lifts its ban from two Apotex facilities in India

Health Canada has lifted its ban from Apotex two Indian facilities. Canada’s drug regulator reinspected the two plants in June and determined

33 drugs were found to be of not of standard quality during Surprise inspection

Recently Karnataka drug control department had conducted surprise inspections to pick up drug samples at random. The drug test labs have issued their result.

Vivimed Labs successfully completes USFDA inspection of its manufacturing facility

Vivimed Labs has recently successfully completed inspection of its API manufacturing facility in Spain. After the completion of inspection Vivimed said “the USFDA inspectors concluded

GMP News & Guidelines Archives:

VIEW HERE

Sea Mist

Stone

IOL Chemicals gains Good Manufacturing Practices Certificate from German Authority

IOL Chemicals and Pharmaceuticals Limitedhas obtained "Certificate of Good Manufacturing Practices Compliance of Manufacturer" from Authority for Health and Consumer Protection, Hamburg, Germany. Apart from this, it has already obtainedthe "Certificate of Suitability"from European Directorate for the Quality of Medicines and Healthcare, (EDQM) France.This certification will enable the Company to improve the sale of Ibuprofen in the European Countries.

Established in 1986, IOL Chemicals & Pharmaceuticals is one of the leading manufacturers of APIs and specialty chemicals with presence in over 57 countries across the world.It manufactures and supplies APIs and specialty chemicals for use in various pharmaceutical, textile, packaging, lamination, pesticides and food processing applications. IOL operates its manufacturing facilities from Barnala (Punjab).

It has 3 stand-alone blocks which are involved in manufacturing of APIs, key pharmaceutical Intermediates and Specialty Chemicals. Plants are designed as per current GMP requirements and clean rooms for finish products are provided with ISO class-8 HVAC system. All plants are designed as per latest technology and ISO standards.